Assessing effectiveness of Pfizer/BioNTech Covid vaccine in adolescents

JAMA Network

What The Study Did: This study evaluated the effectiveness of two doses of the Pfizer/BioNTech COVID-19 vaccine against SARS-CoV-2 infection among 542 adolescents ages 12 to 18.

Authors: Carlos R. Oliveira, M.D., Ph.D., of the Yale School of Medicine in New Haven, Connecticut, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.